Frost & Sullivan

Latest Headlines

Latest Headlines

CMO revenue expected to double in Europe in 6 years

As patents for key blockbuster drugs begin to expire and plant use begins to wane, experts are looking to Europe for a boom in contract manufacturing.

As manufacturing capacity halves, CMO revenue could double in Europe

With blockbuster drugs coming off patent, there will be lots of excess manufacturing capacity in Europe, and that could provide a chance for contract manufacturers to expand there.

Analysts project red-hot Euro growth for CMO market

One of the big trends in pharma outsourcing in recent years has been a move to contracting out manufacturing services. Frost & Sullivan picked up on that trend in a recent market view, plotting...